Advice on employee inventor compensation in the UK following Shanks v Unilever
This guide provides legal commentary on employee compensation schemes following the UK Supreme Court's ruling in Shanks vs Unilver. It has been prepared by Will James of Osborne Clarke with support from other members of the BIA IP Advisory Committee. This guide is not comprehensive and is not intended to constitute legal advice or opinion
In this blog, Jaime Eaton, reflects on this month's Community Connects series, bringing together diverse expertise to tackle the most pressing challenges in our sector.
The BioIndustry Association (BIA) is pleased to announce the appointment of Will James, partner at Osborne Clarke LLP, as Vice-Chair of its Intellectual Property Advisory Committee (IPAC).
BIA has set out its position on mandatory patent description adaptation, warning that it could introduce unnecessary costs and risks for research-intensive life sciences innovators.
Professor Cathy Tralau-Stewart, Executive Director of the Milner Therapeutics Institute, has continued her thought leadership work with an article in Drug Discovery World.
